Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Renal Cell Carcinoma, Clear Cell Adenocarcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01351571
What this trial is testing

An Observational Study of Avastin (Bevacizumab) in Combination With Interferon Alpha-2a as First-Line Treatment in Patients With Advanced and/or Metastatic Renal Cell Carcinoma

Who this might be right for
Renal Cell Cancer
Hoffmann-La Roche 5
Early research (Phase 1)Study completedNCT01100619
What this trial is testing

A Drug-Drug Interaction Study of the Effects of XL184 (Cabozantinib) on Rosiglitazone in Subjects With Solid Tumors

Who this might be right for
Papillary Thyroid CancerFollicular Thyroid CancerHuerthle Cell Thyroid Cancer+1 more
Exelixis 40
Early research (Phase 1)Study completedNCT03556046
What this trial is testing

89Zr-girentuximab ) Dosimetry in CCRC Study - ZIR-DOSE

Who this might be right for
Clear Cell Renal Carcinoma
Radboud University Medical Center 10
Testing effectiveness (Phase 2)Study completedNCT00262886
What this trial is testing

Donor Peripheral Stem Cell or Bone Marrow Transplant in Treating Patients With Relapsed or Refractory Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
University of Rochester 35
Not applicableNot Yet RecruitingNCT06960174
What this trial is testing

Virtual Renality: Assessing the Impact of Virtual Reality on Preoperative Planning in Renal Cancer Surgery

Who this might be right for
Renal Cell Carcinoma (Kidney Cancer)
St. Antonius Hospital 70
Early research (Phase 1)Temporarily pausedNCT06649682
What this trial is testing

68Ga-NYM096/177Lu-NYM096 in Metastatic ccRCC

Who this might be right for
Clear Cell Renal Cell Carcinoma
Peking Union Medical College Hospital 20
Testing effectiveness (Phase 2)Ended earlyNCT00440973
What this trial is testing

Safety Study of Specific Tumor Target Drug Plus Immune System Therapy in Patients With Kidney Cancer

Who this might be right for
Carcinoma, Renal Cell
The Methodist Hospital Research Institute 6
Testing effectiveness (Phase 2)Ended earlyNCT01100242
What this trial is testing

Velcade and Sorafenib in Unresected or Metastatic Renal Cell Carcinoma

Who this might be right for
Metastatic Renal Cell Carcinoma
New Mexico Cancer Research Alliance 17
Testing effectiveness (Phase 2)Looking for participantsNCT06613269
What this trial is testing

68Ga-NY104 PET/CT Guided Radiation Therapy in CcRCC.

Who this might be right for
Clear Cell Renal Cell Carcinoma
Peking Union Medical College Hospital 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT03474497
What this trial is testing

UCDCC#272: IL-2, Radiotherapy, and Pembrolizumab in Patients Refractory to Checkpoint Blockade

Who this might be right for
Non Small Cell Lung CancerMetastatic MelanomaMetastatic Renal Cell Carcinoma+1 more
Megan Daly, MD 18
Testing effectiveness (Phase 2)Ended earlyNCT02495103
What this trial is testing

Vandetanib in Combination With Metformin in People With HLRCC or SDH-Associated Kidney Cancer or Sporadic Papillary Renal Cell Carcinoma

Who this might be right for
Renal Cell CarcinomaHereditary LeiomyomatosisRenal Cell Cancer
National Cancer Institute (NCI) 7
Testing effectiveness (Phase 2)Looking for participantsNCT06005818
What this trial is testing

Molecular Residual Disease (MRD) Guided Adjuvant ThErapy in Renal Cell Carcinoma (RCC)

Who this might be right for
Renal Cell Carcinoma
University of Alabama at Birmingham 100
Early research (Phase 1)Study completedNCT01522820
What this trial is testing

Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors

Who this might be right for
Anaplastic AstrocytomaAnaplastic OligoastrocytomaAnaplastic Oligodendroglioma+62 more
Roswell Park Cancer Institute 18
Early research (Phase 1)Looking for participantsNCT07748988
What this trial is testing

Casdatifan for the Treatment of Refractory Metastatic Clear Cell Renal Cell Carcinoma

Who this might be right for
Refractory Clear Cell Renal Cell CarcinomaMetastatic Clear Cell Renal Cell Carcinoma
Vanderbilt-Ingram Cancer Center 12
Not applicableStudy completedNCT00900042
What this trial is testing

SWOG-9023, DNA Analysis of Tumor Tissue From Patients With Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
SWOG Cancer Research Network 34
Testing effectiveness (Phase 2)Study completedNCT05795595
What this trial is testing

A Safety and Efficacy Study Evaluating CTX131 in Adult Subjects With Relapsed or Refractory Solid Tumors

Who this might be right for
Clear Cell Renal Cell CarcinomaCervical CarcinomaEsophageal Carcinoma+2 more
CRISPR Therapeutics AG 19
Testing effectiveness (Phase 2)Study completedNCT02178722
What this trial is testing

Study to Explore the Safety, Tolerability and Efficacy of MK-3475 in Combination With INCB024360 in Participants With Selected Cancers

Who this might be right for
Microsatellite-instability (MSI) High Colorectal Cancer (CRC)Endometrial CancerHead and Neck Cancer+11 more
Incyte Corporation 444
Not applicableUnknownNCT02208128
What this trial is testing

Molecular Determinants for Therapy Response on Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Heidelberg University 4
Not applicableStudy completedNCT01002937
What this trial is testing

Novel Prognostic Markers in Renal Cancer

Who this might be right for
Renal Cell Carcinoma
Royal Marsden NHS Foundation Trust 182
Testing effectiveness (Phase 2)Study completedNCT00005045
What this trial is testing

Carboxyamidotriazole in Treating Patients With Advanced Kidney Cancer

Who this might be right for
Kidney Cancer
Eastern Cooperative Oncology Group
Next Page